Mark Garrett

Title: Mark Garrett: Innovator in Vaccine Development

Introduction

Mark Garrett is a notable inventor based in Overland Park, KS (US). He has made significant contributions to the field of vaccine development, holding a total of 5 patents. His work focuses on improving vaccine formulations and testing methods, which are crucial for public health.

Latest Patents

Among his latest patents is the "Ready to Use Porcine Vaccine." This invention relates to methods for determining the antigen content of a first antigen in a mixture containing two or more antigens. It also includes a potency test for an antigen in a combination vaccine. The method allows for the determination of the antigen content in a mixture that additionally comprises antibodies capable of binding with the antigen. Another significant patent is the "Potency Test for Vaccine Formulations," which shares similar methodologies for antigen content determination and potency testing in combination vaccines.

Career Highlights

Mark Garrett has worked with reputable companies in the veterinary and pharmaceutical sectors, including Intervet Inc. and Intervet International B.V. His experience in these organizations has allowed him to develop innovative solutions that enhance vaccine efficacy and safety.

Collaborations

Throughout his career, Mark has collaborated with talented professionals such as Urs Peter Bruderer and Michelle Allen. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Mark Garrett's contributions to vaccine development through his innovative patents and collaborations highlight his commitment to improving public health. His work continues to influence the field and pave the way for future advancements in vaccine technology.